B
Benitec Biopharma D
D
BNTC
13.280
USD
0.50
(3.91%)
Post Trading·13.120USD-0.160(-1.20%)
حجم التداول
9,608
الربح لكل سهم
-1
العائد الربحي
-
P/E
-14
حجم السوق
456,225,556
العنوان: Benitec Biopharma
القطاع: الرعاية الصحية
الصناعة: Biotechnology
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
